Haddadin Yezan Munther insider trades
Haddadin Yezan Munther has filed 13 Form 4s with the SEC that we hold, all for Outlook Therapeutics, Inc. (OTLK), as Director. Across all of them we count 6 purchases worth $118.1K and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($39.0K) and 0 sales ($0). The largest single trade was a purchase of 29,743 shares of Outlook Therapeutics, Inc. worth $38.4K, dated 2022-10-06. The first filing on our record is dated 2021-10-07 and the latest 2026-06-03.
Outlook Therapeutics, Inc. (OTLK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-02 | P, purchase reported on Form 4 | 10,000 | $13.9K | 2021-12-02 |
| 2022-10-06 | P, purchase reported on Form 4 | 29,743 | $38.4K | 2022-10-11 |
| 2022-10-07 | P, purchase reported on Form 4 | 3,600 | $4.6K | 2022-10-11 |
| 2024-03-28 | P, purchase reported on Form 4 | 1,882 | $22.2K | 2024-03-29 |
| 2026-05-26 | P, purchase reported on Form 4 | 34,000 | $15.0K | 2026-05-27 |
| 2026-06-02 | P, purchase reported on Form 4 | 29,000 | $24.1K | 2026-06-03 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1718004) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms